Lights and shadows on the efficacy of tocilizumab monotherapy in large vessel giant cell arteritis

Rheumatology (Oxford). 2024 Jan 4;63(1):6-7. doi: 10.1093/rheumatology/kead358.
No abstract available

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Giant Cell Arteritis* / drug therapy
  • Humans
  • Takayasu Arteritis*
  • Treatment Outcome

Substances

  • tocilizumab
  • Antibodies, Monoclonal, Humanized